Drugstore.com CEO resigns
This article was originally published in The Tan Sheet
Executive Summary
Online retailer's President & CEO Kal Raman steps down to "pursue other opportunities," firm announces June 11. CFO Robert Barton will serve as interim CEO as the firm seeks a successor. During Raman's tenure, the company's annual revenues increased from $145 mil. in 2001 to $246 mil. in 2003; the firm achieved EBITDA profitability in the fourth quarter of 2003. Drugstore.com expects revenues for the second quarter to increase 50% to $85 mil. - $89 mil. with an EBITDA loss of $1.1 mil. to $1.8 mil. due to slow ramp-up of the Vision Direct business...
You may also be interested in...
Drugstore.com leadership
Online retailer appoints Dawn Lepore as CEO, effective Oct. 11. Lepore currently is VP-technology, operations and administration at Charles Schwab, a member of Schwab's executive committee and a trustee of SchwabFunds; she will relinquish all of her Schwab positions when she joins Drugstore.com. Drugstore.com board member Melinda Gates says Lepore "brings a great deal of respect and depth from the e-commerce industry as both a leader and an innovator," having designed Schwab's "entire technology platform" and played a "key role" in that firm's online brokerage business. Lepore replaces interim CEO and current CFO Robert Barton, who took over after Kal Raman stepped down in June (1"The Tan Sheet" June 14, 2004, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.